首页> 外文期刊>Journal of immunotoxicology. >Detection and quantification of VEGFR-1 in the nuclei of tumor cells by a new flow cytometry-based method
【24h】

Detection and quantification of VEGFR-1 in the nuclei of tumor cells by a new flow cytometry-based method

机译:一种新的基于流式细胞仪的方法检测和定量肿瘤细胞核中的VEGFR-1

获取原文
           

摘要

Flow cytometry using fluorescent antibodies (FC) is the method of choice for the quantitation of proteins expressed at the surface or inside the cell, but, however, does not allow to selectively measure nuclear expression. We therefore sought to develop a method for the extraction of intact cell nuclei, which can be used for their subsequent immunofluorescent analysis by FC. The studied protein was vascular endothelial growth factor-receptor-type 1 (VEGFR-1) which is important in tumor survival and metastasis. Two human cell lines, A431 (epidermoid carcinoma of skin with low invasive and metastatic potential) and BRO (highly aggressive amelanotic melanoma), were used as examples for tumor cells, and normal human fibroblasts PHF served as a control line. The quality of the extracted nuclei was assessed by their intactness and purity from cytoplasm. The high content of the nuclear markers (PCNA?=?proliferating cell nuclear antigen, lamin A/C) in the extracted nuclei with almost complete absence of the cytoplasmic β-tubulin demonstrated that the protocol can be used to obtain a pure suspension of single intact cell nuclei. The measurement of the nuclear VEGFR-1 content revealed that it was present only in tumor cell nuclei and that in more malignant BRO cells the receptor content was 1.75 times higher than in A431 (p?=?0.014). Thus, the developed method of extraction of cell nuclei for subsequent FC analysis is suitable for the quantitative evaluation of protein content in the native nucleus.
机译:使用荧光抗体(FC)的流式细胞术是定量在细胞表面或内部表达的蛋白质的一种选择方法,但是,它不允许选择性地测量核表达。因此,我们寻求开发一种用于提取完整细胞核的方法,该方法可用于随后通过FC进行的免疫荧光分析。研究的蛋白是血管内皮生长因子受体1(VEGFR-1),在肿瘤的生存和转移中起着重要的作用。两种人类细胞系A431(具有低浸润和转移潜力的表皮样皮肤癌)和BRO(高度侵袭性牙釉质黑色素瘤)被用作肿瘤细胞的实例,而正常人成纤维细胞PHF则作为对照。通过提取的细胞核的完整性和来自细胞质的纯度来评估其质量。几乎完全不存在胞质β-微管蛋白的情况下,提取出的细胞核中的核标记物(PCNAβ=增殖细胞核抗原,lamin A / C)含量很高,证明该方案可用于获得单完整的细胞核。对核VEGFR-1含量的测量表明,它仅存在于肿瘤细胞核中,并且在更多的恶性BRO细胞中,其受体含量是A431的1.75倍(p≤0.014)。因此,为后续的FC分析而开发的提取细胞核的方法适用于定量评估天然核中蛋白质的含量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号